Medical Device Start-Up News, March 2012
Executive Summary
Noteworthy news from medtech start-ups. This month we profile VasoStitch, which has developed technology for streamlining access and closure for transcatheter valve procedures, and ZipLine Medical, which has developed a noninvasive, external skin closure system intended as an alternative to sutures and staples.
You may also be interested in...
Expanding The EVAR Toolbox: A Glimpse Into The Future
The US endovascular abdominal aortic aneurysm repair (EVAR) market is one of the most dynamic device segments in the interventional arena, with growth and innovation driven in large part by an accelerating effort to expand EVAR to a wider patient pool. This movement toward more challenging cases does have a downside in terms of potential complications and uncertain long-term durability as physicians push the envelope of existing technology. However, innovation in this field is continuing at a fairly steady pace, and several important new technologies that could improve the safety and durability of EVAR in more complex anatomy could be introduced in the near future. If these devices live up to their early promise, they are likely to ignite even stronger growth in a market already valued at over $1 billion annually worldwide.
As TAVI Advances, Adjunctive Devices Multiply
As researchers work to more fully understand the risks and durability of transcatheter aortic heart valve implantation (TAVI) procedures, device innovators are already attempting to engineer solutions to some of the more obvious areas of unmet need.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.